{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:02:54Z","timestamp":1791277374551,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/gme.0b013e31829c1431","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T12:19:04Z","timestamp":1377001144000},"page":"227-235","source":"Crossref","is-referenced-by-count":31,"title":["A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17\u03b2-estradiol for moderate to severe vasomotor symptoms in postmenopausal women"],"prefix":"10.1097","volume":"21","author":[{"given":"David F.","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schmelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schaefers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Gerlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Gude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(02)11774-0","article-title":"Hot flushes.","volume":"360","author":"Stearns","year":"2002","journal-title":"Lancet"},{"key":"R4-7-20210211","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of: The North American Menopause Society.","volume":"19","year":"2012","journal-title":"Menopause"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal hormone therapy: an Endocrine Society scientific statement.","volume":"95","author":"Santen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"R9-7-20210211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13697130410001713698","article-title":"Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens.","volume":"7","author":"Schurmann","year":"2004","journal-title":"Climacteric"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/13697137.2011.553971","article-title":"Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.","volume":"14","author":"Lin","year":"2011","journal-title":"Climacteric"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13697130310001651535","article-title":"Safety and efficacy of drospirenone used in a continuous combination with 17-estradiol for prevention of postmenopausal osteoporosis.","volume":"7","author":"Warming","year":"2004","journal-title":"Climacteric"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000232179.60442.84","article-title":"Effects of a new hormone therapy, drospirenone and 17--estradiol, in postmenopausal women with hypertension.","volume":"48","author":"White","year":"2006","journal-title":"Hypertension"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjhyper.2004.12.003","article-title":"Effects of drospirenone17- estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.","volume":"18","author":"Preston","year":"2005","journal-title":"Am J Hypertens"},{"key":"R16-7-20210211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13697130903437375","article-title":"A review of the cardiovascular and breast actions of drospirenone in preclinical studies.","volume":"13","author":"Simoncini","year":"2010","journal-title":"Climacteric"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.fertnstert.2010.07.001","article-title":"Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women.","volume":"95","author":"Villa","year":"2011","journal-title":"Fertil Steril"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13697137.2010.520099","article-title":"Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study.","volume":"14","author":"Gambacciani","year":"2011","journal-title":"Climacteric"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.GME.0000074705.98544.16","article-title":"Low-dose transdermal estradiol for symptomatic perimenopause.","volume":"11","author":"Shulman","year":"2004","journal-title":"Menopause"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13697130008500107","article-title":"Low-dose esterified estrogens (0.3 mgday): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.","volume":"3","author":"Rebar","year":"2000","journal-title":"Climacteric"},{"key":"R21-7-20210211","first-page":"726","article-title":"Initial 17-estradiol dose for treating vasomotor symptoms.","volume":"95","author":"Notelovitz","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R23-7-20210211","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R25-7-20210211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08870449208404294","article-title":"The Womens Health Questionnaire: a measure of mid-aged womens perceptions of their emotional and physical health.","volume":"7","author":"Hunter","year":"1992","journal-title":"Psychol Health"},{"key":"R27-7-20210211","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/gme.0b013e31823de8ba","article-title":"An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.","volume":"19","author":"Gerlinger","year":"2012","journal-title":"Menopause"},{"key":"R28-7-20210211","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13697130701298107","article-title":"Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.","volume":"10","author":"Panay","year":"2007","journal-title":"Climacteric"},{"key":"R29-7-20210211","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.AOG.0000284450.51264.31","article-title":"Lowest effective transdermal 17-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.","volume":"110","author":"Bachmann","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R30-7-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R31-7-20210211","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and EstrogenProgestin Replacement Study (HERS) Research Group.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GME.0b013e31829c1431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:42:52Z","timestamp":1620952972000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201403000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31829c1431","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}